Skip to main content
Equibles

NGEN · Nervgen Pharma Corp. · Financials

Track NGEN — free

Use NGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.19 +0.03 (+1.16%) At close · Sep 11
Rebalance outlook locked
Market Cap
$234.94M
Shares
107.52M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Net Income
-44.12M -81.9%
FY2025 Net Income FY2024–FY2025
Diluted EPS
-0.61 -69.4%
FY2025 Diluted EPS FY2024–FY2025
Operating Cash Flow
-19.5M -15.8%
FY2025 Operating Cash Flow FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024
CAD 13.91M 15.81M
CAD 11.17M 9.37M
CAD 55.8K 28K
CAD -44.12M -24.25M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 1751912 CUSIP 64082X203 13F (30d) 21 filings 21 filers Visit website